NIB Holdings Shares Trail ASX 200 To Start Week: The Latest

NIB Holdings shares (ASX: NHF) fell 9.05% on Monday to close at A$6.73, the worst day for holders in years, despite putting up solid full-year results. So what was in the detail that drove the stock to worst performer on the day?

The Results Driving NIB Shares Lower

At first glance, NIB’s FY26 results appeared respectable. Total income rose 6.2% to A$3.85 billion, while underlying operating profit climbed 9.1% to A$260.9 million, essentially in line with analyst expectations of A$263.3 million. Net profit after tax of A$186.9 million came in 2% ahead of the A$183.8 million consensus, and the company declared a full-year dividend of 34 cents per share, including a 5 cent special dividend beating forecasts of 30 cents by 13%.

The operating expense ratio improved by 110 basis points to 16.6%, demonstrating tangible productivity gains from digital transformation and cost discipline. Incurred claims of A$2.94 billion rose 7.6%, roughly matching expectations, and profit before tax of A$258.4 million was marginally below the A$258.9 million estimate.

Yet markets focused squarely on what lay beneath the headline numbers.

NIB’s core Australian residents health insurance business, despite achieving record sales, saw underlying operating profit fall 9.6% to A$187.9 million. The culprit was a sharp increase in risk equalisation payments, up approximately 10% and around A$10 million above internal expectations combined with elevated rebate and customer acquisition costs.

The sell-off made NHF the worst performer on the ASX 200 to start the week, with the NIB share price falling below both its 50-day and 200-day moving averages, and into negative territory for the year, down 2.04% YTD.

And The Guidance?

For FY27, management guided to group underlying operating profit of A$265 million to A$285 million, excluding the divested Travel business. The midpoint sits slightly ahead of consensus estimates of A$267.6 million, but the guidance came with an explicit caveat regarding ongoing risk equalisation volatility. The board raised its target ordinary dividend payout ratio to 65–75% of net profit, up from prior levels, reflecting confidence in cash generation despite near-term uncertainty.

The company maintained its medium-term net margin target of 6–7% for Australian residents and outlined plans to drive sustainable policyholder growth while expanding its role in health management and care navigation, initiatives designed to improve member engagement and potentially moderate long-term claims inflation.

Markets appeared to interpret the results as evidence that NIB faces a more challenging operating environment than previously priced in. The combination of falling profitability in the core Australian business despite record top-line growth raised concerns that claims inflation is outpacing premium increases and that regulatory constraints limit pricing power.

With NIB shares moving into negative territory YTD following the print, and now 15% lower over the past 12 months, bulls have seen a few important levels fall. The A$7 level that has capped the earlier attempts higher this year is now broken, and the A$6.65-$6.80 zone is now firmly being tested. The week ahead could prove pivotal, and with the ASX 200 Financials struggling to find a bid over the past few weeks, the need for support to step in is clear.